These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35908754)

  • 1. Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practice.
    Li IW; Watts R; Brett T; Radford J; Heal C; Gill G; Hespe C; Vargas-Garcia C; Sullivan DR; Vickery AW; Pang J; Arnold-Reed DE; Chan DC; Watts GF
    Aust J Gen Pract; 2022 Aug; 51(8):604-609. PubMed ID: 35908754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.
    Arnold-Reed DE; Brett T; Troeung L; Vickery A; Garton-Smith J; Bell D; Pang J; Grace T; Bulsara C; Li I; Bulsara M; Watts GF
    BMJ Open; 2017 Oct; 7(10):e017539. PubMed ID: 29061621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting familial hypercholesterolaemia in general practice.
    Kirke A; Watts GF; Emery J
    Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participant experiences of intervention to detect and manage familial hypercholesterolaemia in Australian general practice: A qualitative descriptive study.
    Skoss R; Brett T; Bulsara C; Radford J; Heal C; Gill G; Hespe C; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed DE; Watts GF
    Aust J Gen Pract; 2022 Sep; 51(9):687-694. PubMed ID: 36045626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive study.
    Bulsara C; Brett T; Radford J; Heal C; Gill G; Hespe CM; Vargas-Garcia C; Li IW; Sullivan DR; Vickery AW; Pang J; Arnold-Reed D; Chan DC; Watts GF
    Aust J Gen Pract; 2021 Sep; 50(9):634-640. PubMed ID: 34462767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE
    Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
    Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
    Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolaemia: a model of care for Australasia.
    Watts GF; Sullivan DR; Poplawski N; van Bockxmeer F; Hamilton-Craig I; Clifton PM; O'Brien R; Bishop W; George P; Barter PJ; Bates T; Burnett JR; Coakley J; Davidson P; Emery J; Martin A; Farid W; Freeman L; Geelhoed E; Juniper A; Kidd A; Kostner K; Krass I; Livingston M; Maxwell S; O'Leary P; Owaimrin A; Redgrave TG; Reid N; Southwell L; Suthers G; Tonkin A; Towler S; Trent R;
    Atheroscler Suppl; 2011 Oct; 12(2):221-63. PubMed ID: 21917530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands.
    Marang-van de Mheen PJ; ten Asbroek AH; Bonneux L; Bonsel GJ; Klazinga NS
    Eur Heart J; 2002 Dec; 23(24):1922-30. PubMed ID: 12473254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
    Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
    Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners.
    Brett T; Radford J; Heal C; Hespe CM; Garton-Smith J; Kirke A; Chan DC; Pang J; Watts GF
    Aust J Gen Pract; 2021 Sep; 50(9):616-621. PubMed ID: 34462766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
    Farnier M; Civeira F; Descamps O;
    Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
    Brett T; Qureshi N; Gidding S; Watts GF
    Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
    Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
    Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus?
    Humphries SE
    Atheroscler Suppl; 2011 Oct; 12(2):217-20. PubMed ID: 22230092
    [No Abstract]   [Full Text] [Related]  

  • 19. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M
    Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolaemia: A guide for general practice.
    Brett T; Arnold-Reed D
    Aust J Gen Pract; 2019 Sep; 48(9):650-652. PubMed ID: 31476827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.